Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Regulation Crypto Assets. Document Number: 2026-17183
Buy this Course
FR-26-2164-1
$199.99
This training delivers an in-depth guide to the Global Benchmark for Efficient Drug Pricing (GLOBE) Model, a mandatory Medicare payment initiative. Learn how international price benchmarking transforms inflation rebate calculations for selected Medicare Part B drugs, lowers costs, and preserves care quality. Equip yourself with critical compliance steps, reporting protocols, manufacturer obligations, enforcement details, coinsurance adjustments, and beneficiary protections—all essential for pharmaceutical manufacturers, providers, legal, and compliance professionals impacted by CMS’s new rule.
In this course you will learn the following:
* Understand the background and rationale for the GLOBE Model.
* Identify key compliance requirements for manufacturers, providers, and CMS.
* Learn actionable steps for implementation and reporting.
* Recognize the consequences of non-compliance, including penalties.
* Analyze the impact on Medicare, Medicaid, and other stakeholders.
* Prepare for quality monitoring, beneficiary protections, and reporting obligations.
Listen to a short Podcast discussing this course:
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.
Why This Course is Important
Without this course, you risk missing crucial compliance deadlines, misunderstanding new rebate calculations, facing penalties, or failing to leverage international benchmarking opportunities in Medicare Part B drug pricing.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Global Benchmark for Efficient Drug Pricing (GLOBE) Model.
Key regulatory references include:
Course SKU
FR-26-2243-1